프로그램
진행: 진료지침이사 하윤석
| 시간 | 프로그램 | 연자 및 좌장 |
|---|---|---|
| 08:00~08:20 | Registration | |
| 08:20~08:50 | 상임이사회 | |
| 08:50~09:00 | 개회사 | 대한전립선학회 회장 정재영 |
| 축사 | 대한비뇨의학회 회장 서성일 | |
| 09:00~10:00 | Session I: Novel treatments to improve the quality of life for prostate cancer patients |
유탁근 (을지의대) |
| 조문기 (원자력병원) | ||
| 09:00~09:10 | Intraoperative neuroprotection strategies to optimize functional outcomes in radical prostatectomy | 류재현 (중앙보훈병원) |
| 09:10~09:20 | Strategies for reducing the rectal toxicity after radiation therapy: Hydrogel rectal spacers | 양희조 (순천향의대) |
| 09:20~09:30 | Strategies for reducing the bladder toxicity after radiation therapy: Glycosaminoglycan replacement | 신택준 (계명의대) |
| 09:30~10:00 | Case 및 Panel discussion | 김재헌 (순천향의대) |
| 박홍주 (강원의대) | ||
| 서원익 (인제의대) | ||
| 김종욱 (고려의대) | ||
| 10:00~10:50 | Session II: Advancing prostate cancer therapeutics: Transformative role of PARPis, Radium-223, and LuPSMA |
강택원 (전남의대) |
| 홍성규 (서울의대) | ||
| 10:00~10:07 | Clinical significance of the PEACE-3 Trial: Synergistic effects of Radium-223 and ARPI | 송기현 (국립암센터) |
| 10:07~10:17 | Combination therapy of PARP Inhibitors and ARPI: New paradigm in prostate cancer treatment | 유성현 (전남의대) |
| 10:17~10:27 | Optimizing LuPSMA therapy: LuPSMA in prechemo (PSMAfore) & combination approaches (ENZA-P) | 태범식 (고려의대) |
| 10:27~10:50 | Case 및 Panel discussion | 민경은 (경희의대) |
| 송필현 (영남의대) | ||
| 김원태 (충북의대) | ||
| 김형준 (서울의대) | ||
| 10:50~11:10 | Coffee Break | |
| 11:10~12:10 | Session III: A biopsy showed no cancer: What about this case? |
정재일 (인제의대) |
| 문경현 (울산의대) | ||
| 11:10~11:20 | No tumor, still high PSA: When and how should we perform a repeat biopsy? | 김명 (SNU건전비뇨의학과) |
| 11:20~11:30 | ASAP, PIN: Can we predict patients who will progress to cancer? | 남욱 (울산의대) |
| 11:30~11:40 | Normal PSA, but imaging shows prostate abnormalities: Should we perform a biopsy? | 구자윤 (동남권 원자력의학원) |
| 11:40~12:10 | Case 및 Panel discussion | 한병규 (퍼펙트비뇨의학과) |
| 이중호 (포항세명기독병원) | ||
| 이학민 (서울의대) | ||
| 신유섭 (전북의대) | ||
| 12:10~13:20 | Luncheon Symposium & Lunch | 박재영 (고려의대) |
| Therapeutic Prioritization in mHSPC: Why Early Intensification Matters | 김종욱 (고려의대) | |
| 13:20~14:30 | Session IV: What is the most appropriate method for radical prostatectomy? |
이상은 (SNU 건전비뇨의학과) |
| 이경섭 (계명의대) | ||
| 13:20~13:27 | Open radical prostatectomy: Reflections on cost-effectiveness | 권세윤 (동국의대) |
| 13:27~13:34 | Laparoscopic radical prostatectomy: Alternatives to robotic surgery | 조인창 (국립경찰병원) |
| 13:34~13:41 | Single-port robot assisted radical prostatectomy: This is true minimally invasive surgery | 최중원 (중앙의대) |
| 13:41~13:48 | Multi-port robot assisted radical prostatectomy: We can accomplish more | 김택상 (고신의대) |
| 13:48~13:55 | Evolution of robotic surgery: Da Vinci 5, Medtronic HugoTM, KD-SR-01®, and beyond | 이기수 (동아의대) |
| 13:55~14:30 | Panel discussion | 김태효 (동아의대) |
| 박재영 (고려의대) | ||
| 고영휘 (이화의대) | ||
| 박종욱 (원자력병원) | ||
| 14:30~14:50 | Coffee Break | |
| 14:50~15:50 | Session V: BCR after primary definitive therapy: Fighting back with salvage therapy |
하유신 (가톨릭의대) |
| 전황균 (성균관의대) | ||
| 14:50~15:00 | Emerging role of ARTA monotherapy: Redefining the management of biochemical recurrence | 최세영 (중앙의대) |
| 15:00~15:10 | Application of ARTA with salvage radiation therapy for BCR management in the PSMA PET imaging era | 신동호 (가톨릭의대) |
| 15:10~15:20 | Optimal salvage treatment after BCR in men with primary radiation therapy: sRP, sRT retrial or other therapy | 이상욱 (순천향의대) |
| 15:20~15:50 | Case 및 Panel discussion | 한준현 (파워비뇨의학과) |
| 윤종현 (국립중앙의료원) | ||
| 김윤범 (중앙보훈병원) | ||
| 이현영 (순천향의대) | ||
| 15:50~16:00 | 폐회사 | 대한전립선학회 회장 정재영 |
Copyright(C) by 2025 Prostate Cancer Forum: Guidelines and Consensus.
All rights reserved.
준비,운영 사무국
주소: 서울시 강서구 공항대로 228 리더스타워 1005호 | (주)가온컨벤션
전화 : 02-6956-7989 | 팩스 : 070-8668-1019 | E-mail : gaonpco@gaonpco.com